Безопасен ли myricetin sesquicaprylate при беременности?

Related ingredients

Frequently asked questions

Безопасен ли myricetin sesquicaprylate при беременности?

No harmonised CLP classification, no SCCS/CIR reproductive safety assessment located for this ingredient, and the parent compound myricetin lacks consistent evidence of human teratogenicity; published literature on myricetin mainly reports biological activity and some protective/reparative effects in animal models rather than reproductive hazard. Topical esters are expected to have low but measurable dermal absorption; therefore exposure during pregnancy is low but not nil. (Sources: PubMed review on myricetin; cosmetic ingredient databases listing myricetin sesquicaprylate; EWG myricetin page).

Безопасен ли myricetin sesquicaprylate при грудном вскармливании?

No data found showing reproductive or lactation-specific toxicity or harmonised classification for myricetin sesquicaprylate. Dermal use in nursing parent is expected to give low but measurable exposure; transfer into breastmilk after topical use is unlikely but not studied for this ester specifically.

Безопасен ли myricetin sesquicaprylate для кожи малыша?

No infant-specific safety studies located for the sesquicaprylate ester. Because infants (0–3 yr) have higher skin permeability and surface‑area‑to‑weight ratio, exposure score is increased by +1 compared with adults (adult e=1 → infant e=2). No evidence was found to indicate the ingredient is a developmental toxin or endocrine disruptor at expected topical exposures.

Как VeriMom оценивает myricetin sesquicaprylate?

VeriMom оценивает myricetin sesquicaprylate в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы myricetin sesquicaprylate при беременности?

См. наш список безопасных альтернатив myricetin sesquicaprylate с аналогичной функцией и классификацией без известных рисков.